There was no statistically significant difference in serum MMP3 levels in patients with advanced-stage PD compared to healthy controls [15,31 (8.96, 25.49) vs. 15.37 (11.33, 24.41) ng/ml; P = 0.350]. This evidence concerns the gene MMP3 and Parkinson disease.